Lyell Immunopharma is a clinical-stage T-cell reprogramming company developing cell therapies for patients with solid tumors or hematologic malignancies. The company operates in the United States and focuses on improving durable clinical outcomes through its proprietary genetic and epigenetic reprogramming technology.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.